Nicotinic Acetylcholine Receptors in Alzheimer’s and Parkinson’s Disease
Publisher
Springer New York
Reference271 articles.
1. Thies W, Bleiler L, Alzheimer’s A. Alzheimer’s disease facts and figures. Alzheimers Dement. 2013;9(2):208–45. PubMed PMID: 23507120.
2. Mesulam MM. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer’s disease. J Comp Neurol. 2013;521(18):4124–44. PubMed PMID: 23852922.
3. Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221(2):555–63. PubMed PMID: 21145918.
4. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer’s disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol. 2002;68(3):209–45. PubMed PMID: 12450488.
5. Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat. 2003;26(4):233–42. PubMed PMID: 14729126.